Strive Completes Semler Merger, Expands Bitcoin and Healthcare Focus

Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialStrive Inc ( (ASST) ) has issued an update. On January 16, 2026, Strive completed its previously announced merger with Semler Scientific, with Semler becoming a wholly owned subsidiary and each Semler share converted into the right to receive 21.05 Strive Class A common shares; in connection with the deal, Semler’s 4.25% Convertible Senior Notes due 2030 were amended via a supplemental indenture so that they are now convertible into Strive stock, guaranteed by Strive, with an adjusted initial conversion rate of 275.3887 shares per $1,000 principal amount and up to 34,423,480 Strive shares initially issuable on conversion of the $100 million of notes outstanding. The transaction consolidates two prominent corporate bitcoin treasuries, leaving Strive with roughly 12,797.9 bitcoin and elevating it to the 11th-largest public corporate holder globally, while also reshaping its leadership bench with the appointment of Avik Roy as chief strategy officer to drive monetization and expansion of Semler’s early disease detection business, alongside new board and executive roles for former Semler leaders Eric Semler and Joe Burnett, moves that signal an effort to blend digital-asset treasury strategy with growth in healthcare technology operations. The most recent analyst rating on (ASST) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Strive Inc stock, see the ASST Stock Forecast page. Spark’s Take on ASST Stock According to Spark, TipRanks’ AI Analyst, ASST is a Neutral. The score is held down primarily by severe losses and sustained cash burn reflected in the financial statements. Weak long-term price trends and an unhelpful negative P/E further pressure the rating, while recent corporate actions around the merger, Bitcoin treasury expansion, and preferred dividends provide partial offset. To see Spark’s full report on ASST stock, click here. More about Strive Inc Strive, Inc. is a publicly traded asset management Bitcoin treasury company focused on increasing bitcoin per share and outperforming bitcoin over the long term. Through its SEC-registered investment adviser subsidiary, Strive Asset Management, LLC, the firm manages more than $2 billion in assets and, as of January 16, 2025, holds approximately 12,797.9 bitcoins. Semler Scientific, Inc., now a wholly owned subsidiary of Strive, is a U.S. medical device and software company specializing in early detection and monitoring of chronic diseases, with flagship FDA-cleared product QuantaFlo for point-of-care testing of peripheral arterial disease, and is also among the early U.S. public companies to adopt bitcoin as a primary treasury reserve asset. Average Trading Volume: 123,772,962 Technical Sentiment Signal: Sell Current Market Cap: $924.1M For an in-depth examination of ASST stock, go to TipRanks’ Overview page.